Clinical

Dataset Information

0

Minimal Residual Disease Assessment in Patients With Colorectal Cancer, the MiRDA-C Study


ABSTRACT: This study investigates if circulating tumor DNA (ctDNA) and other tumor-related molecules/chemicals released in the blood can help doctors predict if colorectal cancer may come back or spread. Tumors shed DNA and other cancer related chemicals into the blood that can be identified and studied further to provide information about the cancer. Information gathered from this study may help researchers better understand if ctDNA found in the blood can predict whether colorectal cancer may come back or spread.

DISEASE(S): Stage Ivc Colorectal Cancer Ajcc V8,Stage Iv Colorectal Cancer Ajcc V6,Stage Iva Colorectal Cancer Ajcc V8,Colorectal Adenocarcinoma,Stage Iiic Colorectal Cancer Ajcc V8,Stage Iic Colorectal Cancer Ajcc V8,Stage Iiia Colorectal Cancer Ajcc V8,Neoplasm, Residual,Stage Ivb Colorectal Cancer Ajcc V8,Stage Iia Colorectal Cancer Ajcc V8,Stage I Colorectal Cancer Ajcc V8,Stage Ii Colorectal Cancer Ajcc V8,Colorectal Neoplasms,Stage Iii Colorectal Cancer Ajcc V8,Stage Iib Colorectal Cancer Ajcc V8,Stage Iiib Colorectal Cancer Ajcc V8

PROVIDER: 2366180 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

2021-12-01 | GSE184904 | GEO
2019-01-01 | GSE93203 | GEO
2020-10-28 | GSE142241 | GEO
| 2745213 | ecrin-mdr-crc
| 2379033 | ecrin-mdr-crc
2023-02-10 | GSE220238 | GEO
| 2069746 | ecrin-mdr-crc
2023-12-18 | GSE244989 | GEO
| 63479 | ecrin-mdr-crc
2024-06-10 | GSE178666 | GEO